High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
Source:http://linkedlifedata.com/resource/pubmed/id/11387366
J. Clin. Oncol.
2001
Jun
1
19
11
2927-36
